本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tyra Biosciences, Inc.

10.39
-0.4700-4.33%
盘后10.810.4200+4.04%17:24 EDT
成交量:10.42万
成交额:110.40万
市值:5.53亿
市盈率:-6.36
高:11.19
开:11.00
低:10.38
收:10.86
数据加载中...
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities